Pfizer's childhood vax wins WHO qualification

The WHO has granted prequalification status to Pfizer's children's pneumococcal vaccine, Prevenar 13, paving the way for United Nations agencies and governments to start ordering the product. Report

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

Amarin had big plans for Vascepa after a big label expansion last year, but it lost a patent fight—and now a generic has won FDA approval.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.